XML 21 R4.htm IDEA: XBRL DOCUMENT v3.3.1.900
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2013
Net service revenue $ 1,280,541 $ 1,204,554 $ 1,249,344
Cost of service, excluding depreciation and amortization 725,915 691,061 717,996
General and administrative expenses:      
Salaries and benefits 279,425 292,497 302,564
Non-cash compensation 11,824 5,597 6,519
Other 161,186 143,644 164,991
Provision for doubtful accounts 14,053 16,294 15,882
Depreciation and amortization 20,036 28,307 36,871
U.S. Department of Justice settlement 0 0 150,000
Asset impairment charge 77,268 3,107 9,492
Operating expenses 1,289,707 1,180,507 1,404,315
Operating (loss) income (9,166) 24,047 (154,971)
Other income (expense):      
Interest income 71 94 54
Interest expense (10,783) (8,217) (4,412)
Equity in earnings from equity method investments 9,823 2,991 1,520
Miscellaneous, net 9,747 2,061 4,334
Total other income (expense), net 8,858 (3,071) 1,496
(Loss) income before income taxes (308) 20,976 (153,475)
Income tax (expense) benefit (2,004) (7,671) 58,773
(Loss) income from continuing operations (2,312) 13,305 (94,702)
Discontinued operations, net of tax 0 (216) (3,073)
Net (loss) income (2,312) 13,089 (97,775)
Net loss (income) attributable to noncontrolling interests (709) (313) 1,597
Net (loss) income attributable to Amedisys, Inc. $ (3,021) $ 12,776 $ (96,178)
Basic earnings per common share:      
(Loss) income from continuing operations attributable to Amedisys, Inc. common stockholders $ (0.09) $ 0.40 $ (2.98)
Discontinued operations, net of tax 0.00 (0.01) (0.10)
(Loss) income attributable to Amedisys, Inc. common stockholders $ (0.09) $ 0.39 $ (3.08)
Weighted average shares outstanding 33,018 32,301 31,247
Diluted earnings per common share:      
(Loss) income from continuing operations attributable to Amedisys, Inc. common stockholders $ (0.09) $ 0.40 $ (2.98)
Discontinued operations, net of tax 0.00 (0.01) (0.10)
(Loss) income attributable to Amedisys, Inc. common stockholders $ (0.09) $ 0.39 $ (3.08)
Weighted average shares outstanding 33,018 32,823 31,247
Amounts attributable to Amedisys, Inc. common stockholders:      
(Loss) income from continuing operations $ (3,021) $ 12,992 $ (93,105)
Discontinued operations, net of tax 0 (216) (3,073)
Net (loss) income attributable to Amedisys, Inc. $ (3,021) $ 12,776 $ (96,178)